Thalia Therapeutics Plc (AIM:THAT)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.6250
0.00 (0.00%)
Sep 4, 2026, 10:36 AM GMT

Thalia Therapeutics Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
542248
Market Cap Growth
8.70%110.82%-9.28%-47.17%-46.33%-46.71%
Enterprise Value
431136
Last Close Price
0.010.010.010.010.020.04

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
716.10601.52284.621169.81--
PB Ratio
4.864.083.181.912.073.78
P/TBV Ratio
4.864.083.202.142.073.78

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-363.80123.16509.40--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.01-1.01-0.96-0.86-0.92-0.84
Asset Turnover
0.010.010.010.00--
Quick Ratio
11.7711.776.1214.7327.3410.98
Current Ratio
11.9311.936.2414.8627.8111.01
Return on Equity (ROE)
-140.32%-140.32%-121.41%-77.81%-48.80%-53.37%
Return on Assets (ROA)
-74.91%-74.91%-74.42%-48.50%-33.08%-37.35%
Return on Capital Employed (ROCE)
-108.80%-108.80%-187.50%-111.90%-57.10%-86.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-23.17%-27.58%-51.08%-55.56%-23.80%-19.16%
Buyback Yield / Dilution
-112.82%-112.82%-40.14%-30.29%-2.95%-32.85%